8.96
-0.84 (-8.57%)
| Previous Close | 9.80 |
| Open | 9.67 |
| Volume | 1,311,202 |
| Avg. Volume (3M) | 1,571,165 |
| Market Cap | 1,321,698,688 |
| Price / Earnings (TTM) | 16.00 |
| Price / Earnings (Forward) | 6.77 |
| Price / Sales | 0.310 |
| Price / Book | 0.640 |
| 52 Weeks Range | |
| Earnings Date | 5 May 2025 - 9 May 2025 |
| Profit Margin | 2.77% |
| Operating Margin (TTM) | 12.31% |
| Diluted EPS (TTM) | 0.610 |
| Quarterly Revenue Growth (YOY) | -0.20% |
| Quarterly Earnings Growth (YOY) | 39.00% |
| Total Debt/Equity (MRQ) | 134.99% |
| Current Ratio (MRQ) | 1.33 |
| Operating Cash Flow (TTM) | 541.84 M |
| Levered Free Cash Flow (TTM) | 177.10 M |
| Return on Assets (TTM) | 4.24% |
| Return on Equity (TTM) | 6.23% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | AdaptHealth Corp. | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 5.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | 0.75 |
|
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 11.90% |
| % Held by Institutions | 101.89% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Oep Capital Advisors, L.P. | 30 Sep 2024 | 13,818,180 |
| Skyknight Capital, L.P. | 30 Sep 2024 | 8,580,443 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 16.00 (Baird, 78.57%) | Buy |
| Median | 14.00 (56.25%) | |
| Low | 11.00 (UBS, 22.77%) | Buy |
| Average | 13.80 (54.02%) | |
| Total | 5 Buy | |
| Avg. Price @ Call | 10.66 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Baird | 27 Feb 2025 | 16.00 (78.57%) | Buy | 11.09 |
| Canaccord Genuity | 26 Feb 2025 | 14.00 (56.25%) | Buy | 11.10 |
| RBC Capital | 26 Feb 2025 | 14.00 (56.25%) | Buy | 11.10 |
| Truist Securities | 26 Feb 2025 | 14.00 (56.25%) | Buy | 11.10 |
| UBS | 13 Feb 2025 | 11.00 (22.77%) | Buy | 8.93 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 21 Apr 2025 | Announcement | AdaptHealth Corp. Announces First Quarter 2025 Earnings Release Date and Conference Call |
| 06 Mar 2025 | Announcement | AdaptHealth Corp. to Participate in Upcoming Investor Conferences |
| 25 Feb 2025 | Announcement | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2024 Results and Provides 2025 Outlook |
| 04 Feb 2025 | Announcement | AdaptHealth Corp. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |